Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Get Free Trial
Send Info
Hot Stocks
Alkermes initiates Phase 2 clinical trial of ALKS 2680 » 07:03
04/24/24
04/24
07:03
04/24/24
07:03
ALKS

Alkermes

$24.25 /

+0.18 (+0.75%)

Alkermes announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Tuesday
Hot Stocks
ProQR Therapeutics nominates Maier to board of directors » 07:17
04/23/24
04/23
07:17
04/23/24
07:17
PRQR

ProQR Therapeutics

$2.02 /

+0.05 (+2.54%)

, ALNY

Alnylam

$145.86 /

+1.47 (+1.02%)

ProQR Therapeutics (PRQR)…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a week ago
Hot Stocks
Cerevel Therapeutics' tavapadon meets Phase 3 primary endpoint in Parkinson's » 06:37
04/18/24
04/18
06:37
04/18/24
06:37
CERE

Cerevel Therapeutics

$41.61 /

+0.245 (+0.59%)

Cerevel Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Vigil says interim IGNITE Phase 2 data demonstrate VGL101 potential for ALSP » 16:15
04/17/24
04/17
16:15
04/17/24
16:15
VIGL

Vigil Neuroscience

$2.87 /

-0.19 (-6.21%)

Vigil Neuroscience…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Acumen presents first clinical, biomarker data for ACU193 » 08:06
04/16/24
04/16
08:06
04/16/24
08:06
ABOS

Acumen

$3.54 /

-0.195 (-5.22%)

Acumen Pharmaceuticals…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Alkermes price target lowered by $2 at UBS, here's why » 07:36
04/15/24
04/15
07:36
04/15/24
07:36
ALKS

Alkermes

$24.41 /

-0.595 (-2.38%)

UBS lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:20
04/11/24
04/11
11:20
04/11/24
11:20
PTN

Palatin

$1.92 /

+0.04 (+2.13%)

, LPTX

Leap Therapeutics

$3.96 /

+0.91 (+29.84%)

, BCLI

BrainStorm

/

+

, SAVA

Cassava Sciences

$26.27 /

+1.75 (+7.14%)

, EYEN

Eyenovia

/

+

, CUE

Cue Biopharma

$1.67 /

-0.11 (-6.18%)

, MTEM

Molecular Templates

$1.77 /

-0.06 (-3.28%)

, VBIV

VBI Vaccines

/

+

, SYRS

Syros Pharmaceuticals

$5.52 /

-0.025 (-0.45%)

, ALKS

Alkermes

$25.75 /

-0.385 (-1.47%)

These names in the…

Open Full Text

On The Fly
Yum! downgraded, Cava upgraded: Wall Street's top analyst calls » 09:43
04/10/24
04/10
09:43
04/10/24
09:43
CAVA

Cava Group

$60.27 /

+ (+0.00%)

, VC

Visteon

$114.03 /

+ (+0.00%)

, GDRX

GoodRx

$6.75 /

+ (+0.00%)

, IONS

Ionis Pharmaceuticals

$42.86 /

+ (+0.00%)

, ALNY

Alnylam

$155.94 /

+ (+0.00%)

, CNI

Canadian National

$131.03 /

+ (+0.00%)

, YUM

Yum! Brands

$137.05 /

+ (+0.00%)

, DECK

Deckers Outdoor

$867.84 /

+ (+0.00%)

, MNDY

Monday.com

$215.70 /

+ (+0.00%)

, HXL

Hexcel

$71.14 /

+ (+0.00%)

, BA

Boeing

$178.13 /

+ (+0.00%)

, ADNT

Adient

$31.80 /

+ (+0.00%)

, FND

Floor & Decor

$122.73 /

+ (+0.00%)

, ZION

Zions Bancorp

$43.53 /

+ (+0.00%)

, ALC

Alcon

$82.69 /

+ (+0.00%)

, MKTX

MarketAxess

$226.51 /

+ (+0.00%)

, HIMS

Hims & Hers

$14.56 /

+ (+0.00%)

The most talked about and…

Open Full Text

Recommendations
Alkermes narcolepsy drug 'could be best-in-class,' says Mizuho » 12:53
04/09/24
04/09
12:53
04/09/24
12:53
ALKS

Alkermes

$27.00 /

+1.065 (+4.11%)

Mizuho analyst Uy Ear…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Alkermes price target raised to $50 at Jefferies after 'excellent' NT2 data » 12:04
04/09/24
04/09
12:04
04/09/24
12:04
ALKS

Alkermes

$26.66 /

+0.725 (+2.80%)

Jefferies analyst Akash…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Alnylam participates in a conference call with JPMorgan » 10:41
04/09/24
04/09
10:41
04/09/24
10:41
ALNY

Alnylam

$157.66 /

+1.64 (+1.05%)

Large Cap Biotech Analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Alkermes narcolepsy data better than expected, says Stifel » 08:52
04/09/24
04/09
08:52
04/09/24
08:52
ALKS

Alkermes

$25.93 /

-0.2 (-0.77%)

Stifel says the efficacy…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Alkermes' ALKS 2680 improves wakefulness in Phase 1b narcolepsy study » 07:09
04/09/24
04/09
07:09
04/09/24
07:09
ALKS

Alkermes

$25.93 /

-0.2 (-0.77%)

Alkermes announced…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Alkermes presents results from long-term safety study of LYBALVI » 07:04
04/08/24
04/08
07:04
04/08/24
07:04
ALKS

Alkermes

$26.13 /

+0.33 (+1.28%)

Alkermes announced the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Alnylam Pharmaceuticals presents results from KARDIA-2 Phase 2 study » 08:19
04/07/24
04/07
08:19
04/07/24
08:19
ALNY

Alnylam

$153.58 /

+1.97 (+1.30%)

Alnylam Pharmaceuticals…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Acumen teams with Lonza for advancement of sabirnetug to treat AD » 08:20
04/04/24
04/04
08:20
04/04/24
08:20
ABOS

Acumen

$3.91 /

+0.105 (+2.76%)

, LZAGY

Lonza

$60.03 /

+1.3125 (+2.24%)

Acumen Pharmaceuticals…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Acumen price target lowered by $1 at UBS, here's why » 11:05
03/31/24
03/31
11:05
03/31/24
11:05
ABOS

Acumen

$4.05 /

-0.045 (-1.10%)

UBS lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Acumen files $200M mixed securities shelf 16:37
03/27/24
03/27
16:37
03/27/24
16:37
ABOS

Acumen

$4.10 /

+0.35 (+9.35%)

 
Recommendations
Acumen price target lowered by $11 at BTIG, here's why » 07:21
03/27/24
03/27
07:21
03/27/24
07:21
ABOS

Acumen

$3.75 /

-0.52 (-12.19%)

BTIG lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Alkermes management to meet with Piper Sandler » 05:55
03/27/24
03/27
05:55
03/27/24
05:55
ALKS

Alkermes

$26.77 /

-0.55 (-2.01%)

Meetings to be held in…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a month ago
Hot Stocks
Vigil Neuroscience sees cash runway into 2H25 » 07:07
03/26/24
03/26
07:07
03/26/24
07:07
VIGL

Vigil Neuroscience

$2.99 /

+0.13 (+4.55%)

Cash, cash equivalents,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Vigil Neuroscience reports Q4 EPS (57c), consensus (53c) » 07:07
03/26/24
03/26
07:07
03/26/24
07:07
VIGL

Vigil Neuroscience

$2.99 /

+0.13 (+4.55%)

"Among our many…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Acumen sees cash runway into 1H27 » 07:05
03/26/24
03/26
07:05
03/26/24
07:05
ABOS

Acumen

$4.27 /

-0.05 (-1.16%)

As of December 31, 2023,…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Acumen reports 2023 EPS ($1.08), consensus ($1.07) » 07:05
03/26/24
03/26
07:05
03/26/24
07:05
ABOS

Acumen

$4.27 /

-0.05 (-1.16%)

"2023 was a landmark…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Alkermes management to meet with Piper Sandler » 04:55
03/26/24
03/26
04:55
03/26/24
04:55
ALKS

Alkermes

$27.32 /

+0.04 (+0.15%)

Meetings to be held in…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Dyne Therapeutics CEO Joshua Brumm to step down, John Cox to succeed » 07:47
03/25/24
03/25
07:47
03/25/24
07:47
DYN

Dyne Therapeutics

$28.31 /

-0.895 (-3.07%)

Dyne Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Alkermes management to meet with Piper Sandler » 07:12
03/25/24
03/25
07:12
03/25/24
07:12
ALKS

Alkermes

$27.28 /

+0.33 (+1.22%)

Meetings to be held in…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Vigil Neuroscience appoints Kaufmann as Chief Medical Officer » 07:17
03/20/24
03/20
07:17
03/20/24
07:17
VIGL

Vigil Neuroscience

$2.94 /

-0.185 (-5.93%)

Vigil Neuroscience…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Alkermes initiated with bullish view at Baird, here's why » 16:29
03/18/24
03/18
16:29
03/18/24
16:29
ALKS

Alkermes

$27.51 /

-1.24 (-4.31%)

Baird initiated coverage…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Acumen presents sabirnetug fluid biomarker, target engagement analyses » 08:52
03/08/24
03/08
08:52
03/08/24
08:52
ABOS

Acumen

$4.38 /

-0.075 (-1.69%)

Acumen Pharmaceuticals…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.